NASDAQ:ECOR - Nasdaq - US28531P2020 - Common Stock - Currency: USD
6.02
+0.04 (+0.67%)
The current stock price of ECOR is 6.02 USD. In the past month the price decreased by -25.03%. In the past year, price increased by 6.55%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.4 | 227.16B | ||
ISRG | INTUITIVE SURGICAL INC | 65.86 | 172.95B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.9 | 140.69B | ||
SYK | STRYKER CORP | 28.42 | 132.26B | ||
MDT | MEDTRONIC PLC | 15.47 | 105.94B | ||
BDX | BECTON DICKINSON AND CO | 14.29 | 57.06B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.3 | 42.05B | ||
IDXX | IDEXX LABORATORIES INC | 36.58 | 33.35B | ||
RMD | RESMED INC | 24.08 | 31.27B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 13.89 | 28.52B | ||
DXCM | DEXCOM INC | 41.56 | 26.89B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.04 | 22.19B |
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. The company is headquartered in Rockaway, New Jersey and currently employs 73 full-time employees. The company went IPO on 2018-06-22. The company provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.
ELECTROCORE INC
200 Forge Way, Suite 205
Rockaway NEW JERSEY 07866 US
CEO: Daniel S. Goldberger
Employees: 68
Company Website: https://www.electrocore.com/
Investor Relations: http://investor.electrocore.com
Phone: 19732900097
The current stock price of ECOR is 6.02 USD. The price increased by 0.67% in the last trading session.
The exchange symbol of ELECTROCORE INC is ECOR and it is listed on the Nasdaq exchange.
ECOR stock is listed on the Nasdaq exchange.
11 analysts have analysed ECOR and the average price target is 25.7 USD. This implies a price increase of 326.98% is expected in the next year compared to the current price of 6.02. Check the ELECTROCORE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ELECTROCORE INC (ECOR) has a market capitalization of 43.28M USD. This makes ECOR a Nano Cap stock.
ELECTROCORE INC (ECOR) currently has 68 employees.
ELECTROCORE INC (ECOR) has a support level at 5.56 and a resistance level at 6.22. Check the full technical report for a detailed analysis of ECOR support and resistance levels.
The Revenue of ELECTROCORE INC (ECOR) is expected to grow by 29.95% in the next year. Check the estimates tab for more information on the ECOR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ECOR does not pay a dividend.
ELECTROCORE INC (ECOR) will report earnings on 2025-05-06, after the market close.
ELECTROCORE INC (ECOR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.61).
The outstanding short interest for ELECTROCORE INC (ECOR) is 2.5% of its float. Check the ownership tab for more information on the ECOR short interest.
ChartMill assigns a fundamental rating of 3 / 10 to ECOR. ECOR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months ECOR reported a non-GAAP Earnings per Share(EPS) of -1.61. The EPS increased by 54.78% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -58.06% | ||
ROE | -157.56% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 84% to ECOR. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 20.36% and a revenue growth 29.95% for ECOR